PopRx partners with innoviCares to help patients access medications with fewer barriers

A mobile solution to Canadian healthcare needs

PopRx, the Canadian leader in mobile pharmacy applications, has partnered with STI Technologies Limited’s innoviCares program to offer Canadians a comprehensive mobile solution to their healthcare needs.

PopRx, the Canadian on-demand pharmacy app that connects you to a local independent pharmacist to manage, order and deliver your medication, has taken significant strides in reducing prescription medication costs to Canadians and Canadian employers by partnering with innoviCares to ensure that patients across the country are able to save money on the prescription medications their physician has prescribed.

InnoviCares is a free prescription savings card that helps Canadian patients save money on select prescription medications at pharmacy. Funded by participating pharmaceutical manufacturers, innoviCares works like any insurance card to provide savings at the point of purchase at pharmacy. It also delivers electronic tools to help users manage their healthcare through refill reminders, medication tracking and more.

“We are lucky to be a health tech company in Canada, where we can connect with other Canadian health partners, like innoviCares, who share our vision for reducing costs and increasing access to vital medication for all Canadians,” says Dr. Ali Esmail, CEO of PopRx. “InnoviCares is a great product, and many of our customers, and Canadians everywhere, had no idea that services like this existed, which is why we have integrated it into our PopRx app. We see this as a huge step forward for access to affordable medication that people need across the country.”

Through the partnership, PopRx and innoviCares ensure Canadians are able to receive the prescription medications prescribed by a physician with fewer barriers, including a reduction in cost and access to a pharmacy. When a patient fills or refills a prescription with PopRx, they can use their innoviCares card to save money, live-chat with a pharmacist if needed, and take advantage of free, same-day delivery in major markets across the country.

“Partnering with PopRx was a natural fit for us,” Dave Morton, EVP of STI Technologies, said. “Integration with the PopRx mobile app is just another way we can help patients gain access to medications of their choosing, based on their physician’s advice.”

The PopRx app is available online on both Apple iOS and Android on both the App Store and Play Store. Simply download PopRx for free and create an account to benefit from both PopRx and the innoviCares card today.

PopRx is currently available in the following cities:

  • Toronto
  • Calgary
  • Brampton
  • Vancouver
  • Winnipeg
  • Hamilton
  • Oshawa
  • Kitchener
  • Ajax
  • Guelph
  • Waterloo
  • Lethbridge

InnoviCares Welcomes Olympic Champion Catriona Le May Doan as Ambassador

HALIFAX, NS — (Marketwired – April 11, 2016) – Halifax-based STI Technologies Limited is proud to announce two-time Olympic gold medalist Catriona Le May Doan as their innoviCares ambassador.

Catriona was the world’s fastest woman on ice and the first Canadian to defend a gold medal at any Olympic games. Today, she shares her keys to success both on and off the ice with Canadians across the country.

To become an Olympic gold medalist, Catriona says athletes must choose a routine and training program that best suits their body type and personality. “Everyone is different and something that helps one athlete succeed doesn’t necessarily work for someone else,” says Catriona.

“You really have to explore your options and when you find a program that works for you, it’s important to stick with it — consistency is a major key to success.”

After years of pushing herself to the limit to achieve her goal, Catriona, like many athletes, now suffers from arthritis and chronic pain in her feet and lower back.

“Pain is an unfortunate symptom of high-level competition, but it certainly doesn’t have to control your life,” says Catriona. “My doctor and I chose the treatment that works best for me and I believe every Canadian should have access to a treatment plan that works best for them, regardless of cost or the drug coverage someone has.”

Today, one in every 30 Canadians — like Catriona — uses their free innoviCares card to help them save money on select, brand-name prescriptions at their local pharmacy.

There are more than 100 brands available through the innoviCares card, which is accepted at over 98 per cent of Canadian pharmacies.

“We started innoviCares with the goal of empowering Canadians to take control of their health and we’re thrilled to be helping more than 1.5 million patients access the medications prescribed by their physician,” says Tim Gillis, CEO of STI Technologies Limited. “With more than 100 brands available through innoviCares, now is the time to tell all Canadians about innoviCares.”

InnoviCares will continue to add new medications and other healthcare products to its extensive list in 2016, further supporting Canadians’ choices in managing their health.


About Catriona Le May Doan Olympic Champion Speed Skater | Olympic Broadcaster

In any endeavour, crossing the finish line first — and repeatedly — takes incredible determination, dedication and talent. Catriona Le May Doan knows all about it. Canada’s Athlete of the year in 2002, Catriona Le May Doan is the speed skater whose world recordsetting wins captivated and inspired millions of Canadians. The fastest woman on ice and the Canadian flag bearer at the 2002 Olympic Winter Games opening ceremonies, she won the gold medal in the 500 metre event at those very games, defending her 1998 Olympic 500m gold and became the first Canadian to defend a gold medal at any Olympic Games. She has broken the world record for the event 8 times, and at the 2002 games, set the Olympic record time of 37.30 seconds. She is also a 5-time World Champion. Although she has retired from the world of competitive speed skating, she is still a central figure in the sport. She served as the primary colour commentator for the CTV television broadcast of long track speed skating at the 2010 Vancouver Olympic Winter Games which earned her a Gemini for Best Sports Analyst. Catriona was co-host for CTV’s Olympic Morning at the London 2012 Summer Olympic Games. In 2016 Catriona joined Sport Calgary as the new Senior Director of Community Engagement and Marketing. In her role, Catriona will be a champion of amateur sport in Calgary, building connections with over 400 community sport organizations, and helping support and advocate for the 400,000 active amateur athletes. Le May Doan is not only a champion of sport but a talented motivational speaker as well. Articulate, engaging and fluently bilingual, she connects with audiences by discussing how to achieve personal excellence and motivating people to realize their full potential. Her achievements have landed her in the Canadian Sports Hall of Fame, the Canadian Olympic Committee Sports Hall of Fame, and was appointed an Officer of the Order of Canada. Whenever she speaks, she conveys in a clear and compelling way why she is — and always will be — a champion.

About innoviCares

InnoviCares is Canada’s largest free prescription savings card, covering more than 100 brand-name medications and healthcare products from 23 Canadian pharmaceutical manufacturers.

The innoviCares card works like any drug insurance card at the pharmacy, instantly paying a portion of the cost of participating products. Funded by participating pharmaceutical manufacturers, innoviCares is easy to use and available to all Canadians at no cost.

InnoviCares delivers choice, is easy to use, and supports Canadians to achieve better health outcomes. We’re empowering Canadians to take control of their health.

More information: https://www.innovicares.ca/en
Image Available: http://www.marketwire.com/library/MwGo/2016/4/11/11G092766/Images/catriona- 435d955c8ca9ad82b129f131db606a79.jpg


Media requests may be directed to:
Ashley MacInnis
Communications Specialist
STI Technologies Limited

STI Technologies Limited named one of Deloitte’s Technology Fast50™ Companies

HALIFAX, NS, November 12 2015 – STI Technologies Limited is named today as one of Canada’s fastest growing technology companies in the 18th annual Deloitte Technology Fast50™ awards for demonstrating bold innovation, dedicated leadership and strong growth. STI ranked 41 overall, with a 204 per cent revenue growth from 2011 to 2014.

The Deloitte Technology Fast 50™ program celebrates leaders in the Canadian technology industry and tracks the successful growth of Canadian-grown leaders. The program augments the broader Deloitte North American Technology Fast 500™ initiative with winners automatically eligible for this elite ranking.

“It is an honour to be named one of Deloitte’s Technology Fast 50™ companies,” says Tim Gillis, CEO of STI Technologies Limited. “This award demonstrates the outstanding level of growth and innovation our company has seen over the past years.”

This achievement comes on the heels of STI’s recent recognition as one of Atlantic Canada’s Best Places to Work (Progress Magazine), Fastest Growing Companies (Progress Magazine) and Deloitte’s Best Managed Companies. STI is the only Atlantic Canadian company to make the 2015 Technology Fast50™ list.

“Fast 50™ companies are innovators that transform great ideas into stunning realities,” said Robert Nardi, Technology, Media and Telecommunications Managing Partner for Deloitte Canada. “Their passion and determination makes them all inspiring success stories. They are vital to the Canadian technology sector.”

To qualify for the Deloitte Technology Fast 50TM ranking, companies must have been in business for at least four years, have revenues of at least $5 million, be headquartered in Canada, own proprietary technology, conduct research and development activities in Canada and invest a minimum of five percent of gross revenues in R&D.

About the Deloitte Technology Fast 50™ – The Deloitte Technology Fast 50™ program is Canada’s pre-eminent technology awards program. Celebrating business growth, innovation and entrepreneurship, the program features three distinct categories including the Technology Fast 50™ Ranking, Companies-to-Watch Awards (early-stage Canadian tech companies in business less than four years, with the potential to be a future Deloitte Technology Fast 50™ candidate) and the Leadership Awards (companies that demonstrate technological leadership and innovation within the industry.) Program sponsors include Deloitte, Bank of Montreal, Bennett Jones, OMERS Ventures and Vistara Capital Partners. For further information, visit www.fast50.ca.

About STI Technologies Limited – STI Technologies Limited is a healthcare technology company that provides Canadian patients with greater choice and broader access to the best medications and healthcare products. Through partnerships with Canada’s top pharmaceutical companies, STI supports the healthcare system by delivering financial reimbursement, patient management and patient engagement solutions that improve health outcomes and lower healthcare costs. The company has seen significant growth since the launch of its flagship innoviCares patient engagement platform, and has recently launched Data Solutions and Patient Support Services programs. For further information, visit www.smartsti.com or www.innoviCares.ca.

# # #

Media requests may be directed to:

Ashley MacInnis
Communications Specialist – STI Technologies Limited

STI Technologies Continues to Grow in Quebec with New Additions

HALIFAX, NS – STI Technologies Limited (STI) is pleased to announce the addition of Michel Lamontagne to its Board of Directors and Sylvain Baril as its Quebec-based Senior Manager of Business Development.

Sylvain joins the STI team with more than 15 years’ experience in various roles within the pharmaceutical and healthcare industry.  During his pharmaceutical career, Sylvain has been involved in major social and community investments creating amazing value for Quebec patients.

Based in Verdun and Magog, Quebec, Michel brings a wealth of knowledge of the Quebecois healthcare landscape along with many years’ experience in federal, provincial, municipal and in private sector corporate governance.

A tax lawyer by training, Michel has spent much of his career in the pharmaceutical and healthcare sector. Michel was previously a member of the executive committee of Bristol-Myers Squibb Pharmaceutical Group Canada, former Chair of the RAMQ and former Vice-Chair of the board, Chair of the Vigilance Committee and member of the Audit Committee of the Douglas Mental Health Institute. Michel continues to serve as Chair of Magog Technopole.

The additions of Michel and Sylvain support STI’s continued commitment to the Quebec healthcare system.

“With these appointments to the STI team we will continue to focus our attention on bringing our programs and services to Quebec-based patients,” says Tim Gillis, CEO. “We are committed to addressing the unique needs of the Quebec market through strong, positive relationships.”

STI Technologies Limited is the largest intelligent reimbursement solutions providers to the Canadian healthcare industry, implementing innovative programs on behalf of health care providers of products and services, in the context of responsible patient choice. Using an advanced patient-centric technology platform, all of STI’s programs support greater access and choice to medications and healthcare products to improve patient outcomes.

Dave Morton Appointed Chief Marketing Officer

Dave Morton joins the STI Technologies Limited team with a rich history in pharmaceutical marketing, leadership and agency experience. Known amongst his peers as a seasoned and innovative marketer, Dave prides himself on a customer-centric, strategic leadership and management approach.

Prior to joining STI in early 2015, Dave spent 14 years in various leadership roles, including EVP managing director at JSA Canada – one of the country’s largest healthcare marketing and communications companies. During his time with JSA, Dave was in charge of many market-leading brands, developing a number of award-winning healthcare professional and direct-to-consumer campaigns at the national level.

“We are excited to welcome Dave to our team and look forward to benefiting from his extensive knowledge and experience,” says Tim Gillis, CEO. “Dave’s background in pharmaceutical marketing and sales combined with his commitment to patient-centric care aligns with our strategic priorities, particularly around specialty, adherence and creating effective programs for our clients across the product lifecycle.”

Dave previously spent 10 years with Rhone Poulenc Rorer (now Sanofi Canada) in various progressive sales and marketing positions.

Residing in Montreal for the last 17 years, Dave and his family are excited to return home to their Atlantic Canadian roots.

MEMOTEXT Corp. and STI Technologies Form Strategic Alliance to Superchange Patient Adherence in Canada

MEMOTEXT Corp. announces today the formation of a strategic alliance with STI Technologies Limited to provide state-of-the art digital communications platform and smart-card technology, to improve patient compliance with medications.

The two Canadian companies are collaborating to integrate their technologies to solve a very costly healthcare problem. Despite operating in different spaces of the healthcare industry, both companies have evidence-based methodologies and validated solutions that complement each other. MEMOTEXT’s JAMA published clinically validated digital adherence solutions have been shown to increase patient adherence by 31.4%. While STI’s recent “STI Reimbursement Programs Correlate with Higher Medication Possession Ratios” discussion paper, demonstrates a 30% relative improvement in medication possession ratio (MPR) over a 12-month period for patients benefiting from a reimbursement solution program. By combining MEMOTEXT’s experience in digital health with STI Technologies’ reimbursement solution technology, the two offer a supercharged adherence program that achieves far greater increases in adherence and MPR than either company could accomplish on its own.

This new partnership will integrate MEMOTEXT’s communications platform and personalized behaviour change messaging, with STI Technologies’ personalized reimbursement solutions. The result is an intervention with far greater increases in adherence and MPR. “We are excited that the findings validate what we’ve been hearing from patients and healthcare professionals for years. Patients highly value these reimbursement programs” says Tim Gillis CEO of STI Technologies “Both STI and MEMOTEXT have a focus on personalized healthcare and a proven track record in improving patient’s adherence and their MPR. It’s exciting to see what we can accomplish in the coming years. By combining our technology, methodologies and offerings into integrated solutions, our partnership will revolutionize patient adherence programs in Canada.”

The alliance brings together STI’s reimbursement support programs, which helps patients with their prescriptions and other healthcare expenses, with MEMOTEXT’s proprietary clinical algorithms and evidence based personalized digital communications. The resulting platform integrates financial assistance for health related services and products with personalized adherence reminders to create a system that delivers validated outcomes, real-time, data-driven, support and behaviour change. The end result is a holistic patient adherence program unlike any other offered in Canada.

“With STI’s expertise in helping patients manage their healthcare expenses and our experience in improving adherence, we complement each other extremely well” said Amos Adler, M.Sc., Founder and President of MEMOTEXT “It’s great that two Canadian digital health companies are collaborating to provide integrated, more affordable, and more effective health interventions. It is a truly exciting time for both of our companies.”

Halifax-Based STI Technologies Limited Wins National Business Excellence Award

STI Technologies Limited has been named one of Canada’s Best Managed Companies in 2014. Sponsored by Deloitte, CIBC, National Post, Queen’s School of Business and MacKay CEO Forums, this award recognizes Canadian-owned and -managed companies with revenues of over $10 million for sustained growth, financial performance and management practices.

“We’re thrilled and extremely proud to receive this national award of business excellence,” says STI Technologies CEO Tim Gillis. “Our people are focused on innovation and the delivery of programs to millions of Canadian patients. STI has seen consistent growth over the past few years and has expanded the company with diverse and talented people to meet the needs and expectations of our clients. Every member of our team should take ownership of this award.”

STI Technologies is a Halifax-based health-care technology company that provides Canadian patients with greater choice and broader access to the best medications and health-care products. Led by former CEO Steve Nicolle until the end of 2014, STI has seen sustained growth supporting the health-care system by delivering reimbursement, patient-engagement and patient-management solutions that improve health outcomes through partnerships with Canada’s top pharmaceutical companies.

By making its user-friendly solutions available online and through health-care providers across the country, STI is the leader in its industry, with millions of patients benefiting from its programs. Its free innoviCares patient-benefit plan is the ninth-largest private plan in Canada, covering nearly 100 medications and products from 20 drug manufacturers; to date, it has helped about 800,000 Canadians.

STI’s business model has adapted and evolved over the last 12 years as the company has gained a better understanding of the market challenges faced by its clients.

“As we develop innovative products to meet our clients’ needs, we recognize that this sustained success will lead to improved patient engagement, adherence and continuity of care—and, ultimately, to better health outcomes for many Canadians,” says Gillis.

About Canada’s Best Managed Companies
Every year since the launch of the program in 1993, hundreds of entrepreneurial companies have competed for this designation in a rigorous and independent process that evaluates their management skills and practices. The awards are granted on four levels: Best Managed winner; Requalified member; Gold Standard winner; and Platinum Club member. For more information, visit bestmanagedcompanies.ca.

STI Technologies Limited Celebrates the Two-Year Anniversary of its Free innoviCares Patient Benefit Plan

STI Technologies Limited is marking two years of helping Canadian patients have greater access to medications through its free innoviCares patient-benefit plan. The innoviCares plan includes many types of benefits, such as allowing patients to receive brand-name medications and health-care products at an equal or similar price to the generic alternatives.

When the plan launched, 12 medications were covered; today innoviCares is the ninth-largest private plan in Canada, and covers nearly 100 medications and products from 20 drug manufacturers. There are no monthly fees, and the innoviCares card has been accepted at over 98 per cent of Canadian pharmacies.

“Our innoviCares plan continues to grow,” says Tim Gillis, chief executive officer at STI. “We’re adding more tools, resources and benefits for patients to help patients manage their medications.”

To date, the innoviCares card has helped nearly 800,000 Canadians, with over 50,000 benefitting from the plan each week. In addition to covering such well-known medications as Crestor, Ezetrol, Imovane, and Cipralex, innoviCares also offers free benefits towards such products as diabetes blood-glucose meters and test strips. “The innoviCares plan improves patients’ medication choices,” says Gillis. “The stress that people are under to be able to afford certain medications is huge. We’re here to help them with that.”

Partnering pharmaceutical companies believe that greater access and patient choice to the most effective medications helps lead to better health outcomes. “With this in mind, we’ve added 14 Sanofi products to the innoviCares plan to ensure patient access to brand-name medications prescribed by their physician”, says Tracey Ramsay, Sanofi Canada’s Vice President of Hospital, Specialty and Consumer Health.

STI Technologies Limited is the largest intelligent reimbursement solutions provider to the Canadian healthcare industry, implementing innovative programs on behalf of major pharmaceutical companies. Using their advanced patient-centric technology platform, all of the Halifax-based company’s programs, support greater access and choice to medications and health-care products to improve patient outcomes. Visit smartsti.com to learn more.

STI Technologies Ranks No. 5 on Progress Magazine’s 2014 Fastest Growing Companies List

Progress magazine has ranked STI Technologies Limited No. 5 on its 2014 Fastest Growing Companies list. Now in its 15th year, the list is a highly anticipated ranking of Atlantic Canadian companies that have reported the most significant increase in revenues over the past three years. These companies are setting the pace for the new economy, not just regionally but also nationally.

In 2011 STI Technologies Limited was ranked No. 24 of all companies, with a 37% three-year growth rate. Last year it was No. 7 of companies with less than $25 million revenue, with an 83% growth rate. In 2013 the company was again No. 7, with an impressive 113% growth rate.

“I give the credit for our continued growth to our people,” said incoming CEO Tim Gillis, the former CFO and VP operations. “In 2014 we made several new hires, including at the senior level, which allowed us to deepen our relationships with our clients so they could better see our overall level of sophistication and capabilities. To maintain a growth trajectory in the future, we plan on continued technology and marketing investment, all the time spreading the word about STI and how our programs lead to healthier Canadians.”

STI Technologies Limited connects physicians, patients, pharmacy and pharmaceutical companies with a variety of intelligent reimbursement and data programs that ultimately improve patient outcomes. The Halifax-based company facilitates valuable interactions between each of these four distinct groups, using an advanced patient-centric technology platform to power all of its solutions. Visit smartsti.com to learn more.

The Fastest Growing Companies come from a wide array of sectors. The ones reporting the most rapid growth are in innovation, IT, aerospace and defence, ocean technology and hospitality. “Even companies that are experiencing 40% growth are showing us that a spike in sales in possible, even in challenging markets,” says Progress publisher Neville Gilfoy.

Gillis to Succeed Nicolle as Chief Executive Officer of STI Technologies Limited

Steve Nicolle, CEO of STI Technologies Limited (STI) will be stepping down from his role at the end of the year. Effective January 1, 2015, Tim Gillis will be succeeding Mr. Nicolle, who will continue to serve on the Company’s Board of Directors.

Having worked for STI since 2010, Gillis currently holds the positions of Chief Financial Officer and Vice President of Operations. “Tim has worked closely with me for the past 4 years and knows the business extremely well. Together we completed one of the largest investments in the region with a $17M investment from Imperial Capital Group in 2013,” said Mr. Nicolle.

Nicolle has been CEO of STI since 2010 and has overseen the Company’s significant growth from a local start-up to one of Canada’s leading healthcare IT companies. “Under Steve’s leadership, STI’s revenue has grown by over 500%, and the company has been recognized for four consecutive years as one of the Best Companies to Work in Atlantic Canada,” said Mr. Gillis.

Diagnosed with Multiple Sclerosis in 2012, Nicolle is passionate about the patient support programs that STI creates for pharmaceutical companies. “Now being one of 100,000 Canadians with MS, I appreciate first-hand how important it is to have access to the best medications available”, said Nicolle, “My MS was a catalyst for the timing of this decision but the transition of leadership to Tim Gillis was planned well before my diagnosis.”

Formerly, Gillis held senior positions with a number of successful companies including Stantec, Ernst & Young, Clarke Inc., and Clear Picture Corporation and has been active in our community as a former board member of Halifax’s United Way for nearly 10 years. “We build the most innovative programs to connect patients to their health care and medications,” said Gillis, “The future of the Company is to build on these initiatives with our pharmaceutical partners; further improving health care in Canada – one patient at a time.”

“Tim’s credentials speak for themselves. He is the right person to take STI to the next level”, said Justin MacCormack, head of Healthcare Investing for Imperial Capital and a member of STI’s Board of Directors.

Page 1 of 212